查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1619579

2024 年粪便微生物移植 (FMT) 全球市场报告

Fecal Microbiota Transplantation (FMT) Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

粪便微生物移植（FMT）市场规模预计在未来几年将强劲成长。 2028年，这一数字将以7.0%的复合年增长率成长至11.2亿美元。预测期内的成长是由于困难梭状芽孢桿菌传染病（CDI）盛行率上升、发炎性肠道疾病率增加、研发活动活性化、老年人口增加以及医疗基础设施扩张。这段时期的主要趋势包括建立供体筛检和粪便製备的标准化通讯协定、微生物组分析的进步、粪便处理技术的改进、创新的递送方法以及合成或标准化微生物群製剂的开发，例子包括基础产品的开发。

胃肠道疾病的日益普及预计将在未来几年推动粪便微生物移植（FMT）市场的扩张。胃肠道 (GI) 疾病包括影响胃肠道的多种疾病，包括食道、胃、小肠、大肠（结肠）、直肠和肛门。导致胃肠道疾病增加的因素包括压力水平增加、久坐习惯和加工食品摄取增加。粪便微生物移植已被用于恢復胃肠道疾病患者的健康肠道细菌，特别是在治疗復发性困难梭状芽孢桿菌传染病。例如，根据非营利组织加拿大克隆氏症和结肠炎的报告，加拿大患有发炎性肠道疾病（IBD）的人数正在迅速增加，预计到2023 年，该人数将达到322,600 人（占人口的0.8%）。预计2023年将诊断出11,000例新病例（约每48分钟1例），2035年将增加至14,000例（约每38分钟1例）。因此，胃肠道疾病的盛行率不断上升已成为推动粪便微生物移植（FMT）市场成长的关键因素。

粪便微生物群移植（FMT）市场的主要企业专注于开发创新解决方案，例如基于微生物群的活体生物治疗药物，以提高胃肠道疾病的治疗效果。微生物群活生物疗法涉及使用活微生物作为恢復或改变肠道微生物群的疗法，以治疗各种疾病。例如，2022年11月，瑞士生物製药公司Ferring Pharmaceuticals的REBYOTA（粪便微生物群，live-jslm）获得美国食品药物管理局（FDA）的核准。这种新颖的、一流的活微生物疗法旨在预防 18 岁及以上的个体在接受抗生素治疗復发性 CDI 后復发艰难梭菌感染疾病(CDI)。 REBYOTA 特别适用于预防该年龄层艰难梭菌感染疾病治疗后的復发。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球粪便微生物移植 (FMT) 市场：驱动因素和限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球粪便微生物移植 (FMT) 市场表现：规模与成长，2018-2023 年
  • 全球粪便微生物移植 (FMT) 市场预测：规模与成长，2023-2028 年、2033 年

第六章 市场细分

  • 全球粪便微生物移植 (FMT) 市场：按类型、实际和预测划分，2018-2023 年、2023-2028 年、2033 年
  • 发酵
  • 生的
  • 冷冻保存
  • 按捐赠者类型、绩效和预测分類的全球粪便微生物移植 (FMT) 市场，2018-2023、2023-2028、2033
  • 粪便起源
  • 来自粪便
  • 来自整个微生物组
  • 全球粪便微生物移植 (FMT) 市场：按适应症、表现和预测划分，2018-2023 年、2023-2028 年、2033 年
  • 困难梭状桿菌感染疾病
  • 发炎性肠道疾病
  • METABOLIC INC.
  • 其他的
  • 全球粪便微生物移植 (FMT) 市场：按给药途径、绩效和预测，2018-2023、2023-2028、2033
  • 口服
  • 直肠
  • 鼻胃管
  • 古龙水胶囊
  • 全球粪便微生物移植 (FMT) 市场：按最终用户、实际和预测，2018-2023、2023-2028、2033
  • 医院
  • 专科诊所
  • 其他的

第 7 章 区域/国家分析

  • 全球粪便微生物移植 (FMT) 市场：按地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球粪便微生物移植 (FMT) 市场：按国家、绩效和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 粪便微生物移植 (FMT) 市场：竞争格局
  • 粪便微生物移植 (FMT) 市场：公司简介
    • Ferring Pharmaceuticals
    • Johns Hopkins Medicine
    • Seres Therapeutics
    • Taconic Biosciences
    • Enterome

第31章 其他大型创新企业

  • RebIoTix Inc
  • Finch Therapeutics Group Inc
  • Locus Biosciences
  • Yeda Research and Development Co. Ltd
  • MicrobIoTica Limited
  • CosmosID Inc
  • AOBiome
  • Synthetic Biologics Inc.
  • Osel Inc.
  • OpenBiome
  • Asia MicrobIoTa Bank
  • Taymount Clinic
  • MicroBiome Therapeutics LLC
  • MaaT Pharma SA
  • Kallyope

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r20585

Fecal microbiota transplantation (FMT) is a medical procedure where a healthy donor's fecal material is transplanted into a recipient's gastrointestinal tract to restore the balance of beneficial microorganisms in the gut. This procedure is typically used to treat conditions where the gut microbiota is disrupted, such as recurrent clostridium difficile infection (CDI) that does not respond to standard treatments.

The main types of fecal microbiota transplantation (FMT) are fermentation, fresh, and cryopreservation. Fermentation in Fecal Microbiota Transplantation (FMT) refers to the process by which gut bacteria break down complex carbohydrates and fibers in the gastrointestinal tract, producing short-chain fatty acids and other metabolites that promote gut health. Donor types include stool-derived, fecal-derived, and whole-microbiome derived, used to treat various conditions such as Clostridioides difficile infection, inflammatory bowel disease, metabolic syndrome, and others. It is administered through oral, rectal, nasogastric, and colon capsule routes. The end users include hospitals, specialty clinics, and others.

The fecal microbiota transplantation (FMT) market research report is one of a series of new reports from The Business Research Company that provides fecal microbiota transplantation (FMT) market statistics, including the fecal microbiota transplantation (FMT) industry's global market size, regional shares, competitors with a fecal microbiota transplantation (FMT) market share, detailed fecal microbiota transplantation (FMT) market segments, market trends and opportunities, and any further data you may need to thrive in the fecal microbiota transplantation (FMT) industry. This fecal microbiota transplantation (FMT) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The fecal microbiota transplantation (FMT) market size has grown strongly in recent years. It will grow from $0.80 billion in 2023 to $0.85 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be attributed to a rising awareness of the gut microbiome, expanding therapeutic applications, the growth of personalized medicine, adoption in gastroenterology practices, a higher number of clinical trials, and increased funding and investments.

The fecal microbiota transplantation (FMT) market size is expected to see strong growth in the next few years. It will grow to $1.12 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth during the forecast period can be attributed to the rising incidence of Clostridium difficile infections (CDI), an increasing prevalence of inflammatory bowel diseases, heightened research and development activities, a growing geriatric population, and expanding healthcare infrastructure. Key trends during this period include the creation of standardized protocols for donor screening and stool preparation, advancements in microbiome analysis, improved stool processing technologies, innovative delivery methods, and the development of synthetic or standardized microbiota-based products.

The increasing incidence of gastrointestinal disorders is anticipated to fuel the expansion of the fecal microbiota transplantation (FMT) market in the future. Gastrointestinal (GI) disorders encompass a variety of conditions that impact the gastrointestinal tract, which includes the esophagus, stomach, small intestine, large intestine (colon), rectum, and anus. Factors contributing to the rise in GI disorders include heightened stress levels, sedentary habits, and a greater intake of processed foods. Fecal microbiota transplantation is utilized to restore healthy gut bacteria in patients with gastrointestinal disorders, particularly for the treatment of recurrent Clostridioides difficile infections. For example, Crohn's and Colitis Canada, a non-profit organization, reported that the number of individuals with inflammatory bowel disease (IBD) in Canada is rapidly increasing, projected to rise from 322,600 in 2023 (0.8% of the population) to 470,000 by 2035 (1.1% of the population). In 2023, 11,000 new cases are expected to be diagnosed (approximately one every 48 minutes), with this number increasing to 14,000 by 2035 (approximately one every 38 minutes). Consequently, the growing prevalence of gastrointestinal disorders is a significant factor driving the growth of the fecal microbiota transplantation (FMT) market.

Leading companies in the fecal microbiota transplantation (FMT) market are concentrating on developing innovative solutions, such as microbiota-based live biotherapeutics, to improve treatment effectiveness for gastrointestinal disorders. Microbiota-based live biotherapeutics involve using live microorganisms as therapeutic agents to restore or alter the gut microbiome for treating various diseases. For example, in November 2022, Ferring Pharmaceuticals, a biopharmaceutical company based in Switzerland, received approval from the US Food and Drug Administration (FDA) for REBYOTA (fecal microbiota, live-jslm). This novel, first-in-class microbiota-based live biotherapeutic is designed to prevent the recurrence of Clostridioides difficile infection (CDI) in individuals aged 18 and older, following antibiotic treatment for recurrent CDI. REBYOTA is specifically indicated for preventing the recurrence of Clostridioides difficile (C. difficile) infection in this age group after such treatment.

In October 2022, SYNLAB Group, a Germany-based provider of medical diagnostic services, formed a partnership with Microba to improve access to advanced microbiome analysis and enhance patient health management. The collaboration aims to expand the availability of the myBIOME test across Europe and Latin America, building on its success in Spain and Colombia. Microba, an Australia-based biotechnology company, specializes in fecal microbiota transplantation (FMT) research and application.

Major companies operating in the fecal microbiota transplantation (FMT) market are Ferring Pharmaceuticals, Johns Hopkins Medicine, Seres Therapeutics, Taconic Biosciences, Enterome, Rebiotix Inc, Finch Therapeutics Group Inc, Locus Biosciences, Yeda Research and Development Co. Ltd, Microbiotica Limited, CosmosID Inc, AOBiome, Synthetic Biologics Inc., Osel Inc., OpenBiome, Asia Microbiota Bank, Taymount Clinic, MicroBiome Therapeutics LLC, MaaT Pharma SA, Kallyope

North America was the largest region in the fecal microbiota transplantation (FMT) market in 2023. The regions covered in the fecal microbiota transplantation (FMT) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fecal microbiota transplantation (FMT) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fecal microbiota transplantation (FMT) market consists of revenues earned by entities by providing services such as donor screening and testing, microbiome assessment, stool collection, processing and preparation, endoscopic delivery, clinical monitoring, and symptom management. The market value includes the value of related goods sold by the service provider or included within the service offering. The fecal microbiota transplantation (FMT) market also includes sales of oral capsules, colonoscopy-based FMT, nasogastric or nasoduodenal tube and lyophilized (freeze-dried) stool. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fecal Microbiota Transplantation (FMT) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fecal microbiota transplantation (FMT) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fecal microbiota transplantation (FMT) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fecal microbiota transplantation (FMT) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Fermentation; Fresh; Cryopreservation
  • 2) By Donor Type: Stool-Derived; Fecal-Derived; Whole-Microbiome Derived
  • 3) By Indication: Clostridioides Difficile Infection; Inflammatory Bowel Disease; Metabolic Syndrome; Other Indications
  • 4) By Administration Route: Oral; Rectal; Nasogastric; Colon Capsule
  • 5) By End-User: Hospitals; Specialty Clinics; Other End-Users
  • Companies Mentioned: Ferring Pharmaceuticals; Johns Hopkins Medicine; Seres Therapeutics; Taconic Biosciences; Enterome
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fecal Microbiota Transplantation (FMT) Market Characteristics

3. Fecal Microbiota Transplantation (FMT) Market Trends And Strategies

4. Fecal Microbiota Transplantation (FMT) Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Fecal Microbiota Transplantation (FMT) Market Size and Growth

  • 5.1. Global Fecal Microbiota Transplantation (FMT) Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Fecal Microbiota Transplantation (FMT) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Fecal Microbiota Transplantation (FMT) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Fecal Microbiota Transplantation (FMT) Market Segmentation

  • 6.1. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Fermentation
  • Fresh
  • Cryopreservation
  • 6.2. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Stool-Derived
  • Fecal-Derived
  • Whole-Microbiome Derived
  • 6.3. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Clostridioides Difficile Infection
  • Inflammatory Bowel Disease
  • Metabolic Syndrome
  • Other Indications
  • 6.4. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By Administration Route, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Rectal
  • Nasogastric
  • Colon Capsule
  • 6.5. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End-Users

7. Fecal Microbiota Transplantation (FMT) Market Regional And Country Analysis

  • 7.1. Global Fecal Microbiota Transplantation (FMT) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Fecal Microbiota Transplantation (FMT) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market

  • 8.1. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Fecal Microbiota Transplantation (FMT) Market

  • 9.1. China Fecal Microbiota Transplantation (FMT) Market Overview
  • 9.2. China Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Fecal Microbiota Transplantation (FMT) Market

  • 10.1. India Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Fecal Microbiota Transplantation (FMT) Market

  • 11.1. Japan Fecal Microbiota Transplantation (FMT) Market Overview
  • 11.2. Japan Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Fecal Microbiota Transplantation (FMT) Market

  • 12.1. Australia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Fecal Microbiota Transplantation (FMT) Market

  • 13.1. Indonesia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Fecal Microbiota Transplantation (FMT) Market

  • 14.1. South Korea Fecal Microbiota Transplantation (FMT) Market Overview
  • 14.2. South Korea Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Fecal Microbiota Transplantation (FMT) Market

  • 15.1. Western Europe Fecal Microbiota Transplantation (FMT) Market Overview
  • 15.2. Western Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Fecal Microbiota Transplantation (FMT) Market

  • 16.1. UK Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Fecal Microbiota Transplantation (FMT) Market

  • 17.1. Germany Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Fecal Microbiota Transplantation (FMT) Market

  • 18.1. France Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Fecal Microbiota Transplantation (FMT) Market

  • 19.1. Italy Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Fecal Microbiota Transplantation (FMT) Market

  • 20.1. Spain Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Fecal Microbiota Transplantation (FMT) Market

  • 21.1. Eastern Europe Fecal Microbiota Transplantation (FMT) Market Overview
  • 21.2. Eastern Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Fecal Microbiota Transplantation (FMT) Market

  • 22.1. Russia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Fecal Microbiota Transplantation (FMT) Market

  • 23.1. North America Fecal Microbiota Transplantation (FMT) Market Overview
  • 23.2. North America Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Fecal Microbiota Transplantation (FMT) Market

  • 24.1. USA Fecal Microbiota Transplantation (FMT) Market Overview
  • 24.2. USA Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Fecal Microbiota Transplantation (FMT) Market

  • 25.1. Canada Fecal Microbiota Transplantation (FMT) Market Overview
  • 25.2. Canada Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Fecal Microbiota Transplantation (FMT) Market

  • 26.1. South America Fecal Microbiota Transplantation (FMT) Market Overview
  • 26.2. South America Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Fecal Microbiota Transplantation (FMT) Market

  • 27.1. Brazil Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Fecal Microbiota Transplantation (FMT) Market

  • 28.1. Middle East Fecal Microbiota Transplantation (FMT) Market Overview
  • 28.2. Middle East Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Fecal Microbiota Transplantation (FMT) Market

  • 29.1. Africa Fecal Microbiota Transplantation (FMT) Market Overview
  • 29.2. Africa Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Fecal Microbiota Transplantation (FMT) Market Competitive Landscape And Company Profiles

  • 30.1. Fecal Microbiota Transplantation (FMT) Market Competitive Landscape
  • 30.2. Fecal Microbiota Transplantation (FMT) Market Company Profiles
    • 30.2.1. Ferring Pharmaceuticals
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johns Hopkins Medicine
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Seres Therapeutics
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Taconic Biosciences
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Enterome
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Fecal Microbiota Transplantation (FMT) Market Other Major And Innovative Companies

  • 31.1. Rebiotix Inc
  • 31.2. Finch Therapeutics Group Inc
  • 31.3. Locus Biosciences
  • 31.4. Yeda Research and Development Co. Ltd
  • 31.5. Microbiotica Limited
  • 31.6. CosmosID Inc
  • 31.7. AOBiome
  • 31.8. Synthetic Biologics Inc.
  • 31.9. Osel Inc.
  • 31.10. OpenBiome
  • 31.11. Asia Microbiota Bank
  • 31.12. Taymount Clinic
  • 31.13. MicroBiome Therapeutics LLC
  • 31.14. MaaT Pharma SA
  • 31.15. Kallyope

32. Global Fecal Microbiota Transplantation (FMT) Market Competitive Benchmarking

33. Global Fecal Microbiota Transplantation (FMT) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Fecal Microbiota Transplantation (FMT) Market

35. Fecal Microbiota Transplantation (FMT) Market Future Outlook and Potential Analysis

  • 35.1 Fecal Microbiota Transplantation (FMT) Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Fecal Microbiota Transplantation (FMT) Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Fecal Microbiota Transplantation (FMT) Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer